MARY COOPER: Open Payments
NPI 1588174700 · ROANOKE RAPIDS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 50 payments from 17 companies in 2025. Trend: 2023 $512 · 2024 $747 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $190 |
| Lilly USA, LLC | 8 | $152 |
| AstraZeneca Pharmaceuticals LP | 2 | $142 |
| ABBVIE INC. | 5 | $93 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $64 |
| Amgen Inc. | 3 | $46 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
Products named: BREZTRI, ZEPBOUND, Ozempic, JARDIANCE, TRELEGY ELLIPTA, CAPLYTA, Wegovy, VRAYLAR.
Industry payments across NC — which companies pay providers there.
